Skip to main content

Gout: ULT Therapy (Recommended for eMeasure Trial Approval)

CBE ID
2550e
1.4 Project
Primary Care and Chronic Illness
Endorsed
Endorsement Status
Approval for Trial Use Removed
E&M Cycle
Spring 2019
Is Under Review
No
1.3 Measure Description

Percentage of patients aged 18 and older with a diagnosis of gout and either tophus/tophi or at least two gout flares (attacks) in the past year who have a serum urate level > 6.0 mg/dL, who are prescribed urate lowering therapy (ULT)

    • 1.14 Numerator

      Patients who are prescribed urate lowering therapy (ULT)

    • 1.15 Denominator

      Adult patients aged 18 and older with a diagnosis of gout and a serum urate level > 6.8 mg/dL who have at least one of the following: presence of tophus/tophi or two or more gout flares (attacks) in the past year

    • Exclusions

      None

    • Most Recent Endorsement Activity
      Approval for Trial Use Removed Primary Care and Chronic Illness Spring Cycle 2019
      Initial Endorsement
      Last Updated
      Removal Date